Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™". The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012.
Today’s pharmaceutical industry faces unprecedented challenges. Our latest research report explores the key challenges facing pharma companies and includes case studies to provide context on the industry’s challenges.
